Vγ2 x PD-L1, a Bispecific Antibody Targeting Both the Vγ2 TCR and PD-L1, Improves the Anti-Tumor Response of Vγ2Vδ2 T Cell.
Yang R, He Q, Zhou H, Gong C, Wang X, Song X, Luo F, Lei Y, Ni Q, Wang Z, Xu S, Xue Y, Zhang M, Wen H, Fang L, Zeng L, Yan Y, Shi J, Zhang J, Yi J, Zhou P.
Yang R, et al. Among authors: zhang m, zhang j.
Front Immunol. 2022 Jun 17;13:923969. doi: 10.3389/fimmu.2022.923969. eCollection 2022.
Front Immunol. 2022.
PMID: 35784353
Free PMC article.